Cargando…
Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells
Platinum-based chemotherapeutic regimens are ultimately unsuccessful due to intrinsic or acquired drug resistance. Understanding the molecular basis for platinum drug sensitivity/resistance is necessary for the development of new drugs and therapeutic regimens. In an effort to identify such determin...
Autores principales: | Roberts, D, Schick, J, Conway, S, Biade, S, Laub, P B, Stevenson, J P, Hamilton, T C, O'Dwyer, P J, Johnson, S W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361951/ https://www.ncbi.nlm.nih.gov/pubmed/15726096 http://dx.doi.org/10.1038/sj.bjc.6602447 |
Ejemplares similares
-
Gene expression profiling of human ovarian tumours
por: Biade, S, et al.
Publicado: (2006) -
A seven-gene prognostic model for platinum-treated ovarian carcinomas
por: Sabatier, R, et al.
Publicado: (2011) -
The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer
por: Patel, Monal, et al.
Publicado: (2021) -
Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles
por: Rickardson, L, et al.
Publicado: (2005) -
Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer
por: Lim, S L, et al.
Publicado: (2008)